These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19470399)

  • 61. [Elucidating the structure of two cyclotides of Viola tianshanica maxim by MALDI TOF/TOF MS analysis].
    Xiang B; Du GH; Wang XC; Zhang SX; Qin XY; Kong JQ; Cheng KD; Li YJ; Wang W
    Yao Xue Xue Bao; 2010 Nov; 45(11):1402-9. PubMed ID: 21361040
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclotides as grafting frameworks for protein engineering and drug design applications.
    Poth AG; Chan LY; Craik DJ
    Biopolymers; 2013 Sep; 100(5):480-91. PubMed ID: 23893608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Formation of cyclotides and variations in cyclotide expression in Oldenlandia affinis suspension cultures.
    Seydel P; Gruber CW; Craik DJ; Dörnenburg H
    Appl Microbiol Biotechnol; 2007 Nov; 77(2):275-84. PubMed ID: 17786427
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1.
    Daly NL; Gustafson KR; Craik DJ
    FEBS Lett; 2004 Sep; 574(1-3):69-72. PubMed ID: 15358541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The conserved glu in the cyclotide cycloviolacin O2 has a key structural role.
    Göransson U; Herrmann A; Burman R; Haugaard-Jönsson LM; Rosengren KJ
    Chembiochem; 2009 Sep; 10(14):2354-60. PubMed ID: 19735083
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.
    Wang CK; Colgrave ML; Gustafson KR; Ireland DC; Goransson U; Craik DJ
    J Nat Prod; 2008 Jan; 71(1):47-52. PubMed ID: 18081258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elucidating the structure of cyclotides by partial acid hydrolysis and LC-MS/MS analysis.
    Sze SK; Wang W; Meng W; Yuan R; Guo T; Zhu Y; Tam JP
    Anal Chem; 2009 Feb; 81(3):1079-88. PubMed ID: 19178340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cyclotides as natural anti-HIV agents.
    Ireland DC; Wang CK; Wilson JA; Gustafson KR; Craik DJ
    Biopolymers; 2008; 90(1):51-60. PubMed ID: 18008336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.
    Gould A; Ji Y; Aboye TL; Camarero JA
    Curr Pharm Des; 2011 Dec; 17(38):4294-307. PubMed ID: 22204428
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclotides: Overview and Biotechnological Applications.
    Gould A; Camarero JA
    Chembiochem; 2017 Jul; 18(14):1350-1363. PubMed ID: 28544675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue-specific expression of head-to-tail cyclized miniproteins in Violaceae and structure determination of the root cyclotide Viola hederacea root cyclotide1.
    Trabi M; Craik DJ
    Plant Cell; 2004 Aug; 16(8):2204-16. PubMed ID: 15295104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclotides: Disulfide-rich peptide toxins in plants.
    Huang YH; Du Q; Craik DJ
    Toxicon; 2019 Oct; 172():33-44. PubMed ID: 31682883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An overview of acyclotides: Past, present and future.
    Tammineni R; Gulati P; Kumar S; Mohanty A
    Phytochemistry; 2020 Feb; 170():112215. PubMed ID: 31812106
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design.
    Clark RJ; Daly NL; Craik DJ
    Biochem J; 2006 Feb; 394(Pt 1):85-93. PubMed ID: 16300479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solution structure of the cyclotide palicourein: implications for the development of a pharmaceutical framework.
    Barry DG; Daly NL; Bokesch HR; Gustafson KR; Craik DJ
    Structure; 2004 Jan; 12(1):85-94. PubMed ID: 14725768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NMR and protein structure in drug design: application to cyclotides and conotoxins.
    Daly NL; Rosengren KJ; Henriques ST; Craik DJ
    Eur Biophys J; 2011 Apr; 40(4):359-70. PubMed ID: 21290122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclotide discovery in Gentianales revisited--identification and characterization of cyclic cystine-knot peptides and their phylogenetic distribution in Rubiaceae plants.
    Koehbach J; Attah AF; Berger A; Hellinger R; Kutchan TM; Carpenter EJ; Rolf M; Sonibare MA; Moody JO; Wong GK; Dessein S; Greger H; Gruber CW
    Biopolymers; 2013 Sep; 100(5):438-52. PubMed ID: 23897543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
    Craik DJ; Clark RJ; Daly NL
    Expert Opin Investig Drugs; 2007 May; 16(5):595-604. PubMed ID: 17461734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyclotides as drug design scaffolds.
    Craik DJ; Du J
    Curr Opin Chem Biol; 2017 Jun; 38():8-16. PubMed ID: 28249194
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.
    Garcia AE; Camarero JA
    Curr Mol Pharmacol; 2010 Nov; 3(3):153-63. PubMed ID: 20858197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.